The Physician Payment Sunshine Act, operated by the Centers for Medicare and Medicaid Services ("CMS") as the Open Payments Program, was enacted to increase transparency around relationships that physicians and teaching hospitals have with manufacturers and group purchasing organizations. ASTRO works to educate its membership about the Open Payments Program, including alerting them to the types of activities that will result in data being reported about them and the steps they need to take to review data after it has been reported. ASTRO maintains FAQs on this topic for its members. For the most comprehensive and up-to-date information about the Open Payments Program, visit the CMS website.
We are committed to abiding by the highest business standards and engaging in behaviors that will enhance the reputation and maintain the integrity of ASTRO Corporate Membership. To this end, we look to the ASTRO code to provide a framework and mechanisms for setting minimum standards of behavior, educating Members, monitoring Industry activities and development and promoting self-regulation and disciplinary functions.
As a Corporate Member, we agree to adhere to the ASTRO Corporate Member Code of Ethics in the way we conduct our business activities as follows:
ASTRO’s organizational mission statement and strategic plan provide principled guidance for all corporate relationships. The types of corporate relationships developed by ASTRO shall be consistent with the core purpose and values of ASTRO. All corporate relationships must be evaluated against ASTRO’s primary objective to provide representation and leadership for the profession and to advance public health.
ASTRO should participate in corporate arrangements when these guidelines are met and the arrangements prove to further ASTRO’s purpose, avoid conflict of interest and safeguard ASTRO’s objectivity.
Corporate relationship shall mean any arrangement or transaction between ASTRO and a corporation that furthers the mission of ASTRO.
1. Any proposed relationship must be evaluated to ensure that it is driven by a commitment to the general principles established in the Society’s mission.
2. The relationship must preserve and promote trust in the Society by the medical profession, medical corporations, regulatory agencies and the public.
3. The relationship must maintain objectivity with regard to health issues.
4. The relationship should be mutually beneficial with clearly defined and transparent expectations from ASTRO and from the industry perspective.